3-66500338-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015541.3(LRIG1):​c.70C>G​(p.Leu24Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.941 in 1,495,944 control chromosomes in the GnomAD database, including 680,117 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 51667 hom., cov: 31)
Exomes 𝑓: 0.96 ( 628450 hom. )

Consequence

LRIG1
NM_015541.3 missense

Scores

1
1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.34

Publications

20 publications found
Variant links:
Genes affected
LRIG1 (HGNC:17360): (leucine rich repeats and immunoglobulin like domains 1) Predicted to act upstream of or within several processes, including innervation; otolith morphogenesis; and sensory perception of sound. Predicted to be located in plasma membrane. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.33378E-7).
BP6
Variant 3-66500338-G-C is Benign according to our data. Variant chr3-66500338-G-C is described in ClinVar as Benign. ClinVar VariationId is 403058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015541.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRIG1
NM_015541.3
MANE Select
c.70C>Gp.Leu24Val
missense
Exon 1 of 19NP_056356.2
LRIG1
NM_001377344.1
c.70C>Gp.Leu24Val
missense
Exon 1 of 18NP_001364273.1
LRIG1
NM_001377345.1
c.-563+755C>G
intron
N/ANP_001364274.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRIG1
ENST00000273261.8
TSL:1 MANE Select
c.70C>Gp.Leu24Val
missense
Exon 1 of 19ENSP00000273261.3
LRIG1
ENST00000383703.3
TSL:1
c.70C>Gp.Leu24Val
missense
Exon 1 of 20ENSP00000373208.3
LRIG1
ENST00000498287.5
TSL:4
n.171+755C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.770
AC:
116535
AN:
151300
Hom.:
51662
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.999
Gnomad AMR
AF:
0.862
Gnomad ASJ
AF:
0.908
Gnomad EAS
AF:
0.809
Gnomad SAS
AF:
0.956
Gnomad FIN
AF:
0.936
Gnomad MID
AF:
0.920
Gnomad NFE
AF:
0.986
Gnomad OTH
AF:
0.805
GnomAD2 exomes
AF:
0.920
AC:
107645
AN:
117024
AF XY:
0.930
show subpopulations
Gnomad AFR exome
AF:
0.248
Gnomad AMR exome
AF:
0.876
Gnomad ASJ exome
AF:
0.911
Gnomad EAS exome
AF:
0.806
Gnomad FIN exome
AF:
0.930
Gnomad NFE exome
AF:
0.985
Gnomad OTH exome
AF:
0.922
GnomAD4 exome
AF:
0.961
AC:
1291503
AN:
1344536
Hom.:
628450
Cov.:
52
AF XY:
0.963
AC XY:
640759
AN XY:
665604
show subpopulations
African (AFR)
AF:
0.268
AC:
7543
AN:
28156
American (AMR)
AF:
0.877
AC:
23934
AN:
27278
Ashkenazi Jewish (ASJ)
AF:
0.915
AC:
20832
AN:
22760
East Asian (EAS)
AF:
0.832
AC:
26606
AN:
31980
South Asian (SAS)
AF:
0.961
AC:
71325
AN:
74224
European-Finnish (FIN)
AF:
0.944
AC:
35473
AN:
37578
Middle Eastern (MID)
AF:
0.928
AC:
4491
AN:
4838
European-Non Finnish (NFE)
AF:
0.989
AC:
1050662
AN:
1062194
Other (OTH)
AF:
0.912
AC:
50637
AN:
55528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1714
3429
5143
6858
8572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21050
42100
63150
84200
105250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.770
AC:
116552
AN:
151408
Hom.:
51667
Cov.:
31
AF XY:
0.772
AC XY:
57076
AN XY:
73978
show subpopulations
African (AFR)
AF:
0.294
AC:
12149
AN:
41350
American (AMR)
AF:
0.863
AC:
13130
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.908
AC:
3144
AN:
3464
East Asian (EAS)
AF:
0.809
AC:
4049
AN:
5002
South Asian (SAS)
AF:
0.956
AC:
4614
AN:
4824
European-Finnish (FIN)
AF:
0.936
AC:
9824
AN:
10496
Middle Eastern (MID)
AF:
0.918
AC:
268
AN:
292
European-Non Finnish (NFE)
AF:
0.986
AC:
66772
AN:
67740
Other (OTH)
AF:
0.803
AC:
1691
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
656
1312
1969
2625
3281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.793
Hom.:
3163
Bravo
AF:
0.741
ESP6500AA
AF:
0.475
AC:
1309
ESP6500EA
AF:
0.983
AC:
5325
ExAC
AF:
0.882
AC:
85758
Asia WGS
AF:
0.820
AC:
2815
AN:
3434

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

LRIG1-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
16
DANN
Benign
0.90
DEOGEN2
Benign
0.076
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.50
D
MetaRNN
Benign
7.3e-7
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
1.3
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.55
N
REVEL
Benign
0.062
Sift
Benign
0.093
T
Sift4G
Benign
0.23
T
Polyphen
0.28
B
Vest4
0.16
MPC
0.095
ClinPred
0.0070
T
GERP RS
3.1
Varity_R
0.13
gMVP
0.49
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1403626; hg19: chr3-66550762; COSMIC: COSV56236839; COSMIC: COSV56236839; API